Psilocybin-induced takotsubo cardiomyopathy
Wiktoria Julia Kotts, David Gamble, Dana Dawson, David E. Connor
BMJ Case Reports May 1, 2022 DOI: 10.1136/bcr-2021-245863 via OpenAlex
Summary
AI-generated from the abstractA case of takotsubo cardiomyopathy occurred after recreational ingestion of Psilocybe semilanceata (magic mushrooms). The patient had respiratory distress and pulmonary edema that responded to standard medical treatment. Diagnostic tests included echocardiogram, cardiac MRI, and angiogram. Based on a literature search, this appears to be only the second recognized case reported in published medical literature.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | Patient who ingested Psilocybe semilanceata |
| Topics | Psilocybin |
| Keywords | Cardiomyopathy Takotsubo syndrome Cardiology Medicine |
| Citations | 10 |
| Key finding | Takotsubo cardiomyopathy can occur after ingestion of Psilocybe semilanceata, with this being the second reported case. |
Abstract
We present a case of takotsubo cardiomyopathy following recreational ingestion of Psilocybe semilanceata (known as ‘magic mushrooms’). The patient presented with respiratory distress and pulmonary oedema responding to standard medical measures. Investigations included: echocardiogram, cardiac MRI and angiogram. Based on our search, we suggest this is only the second recognised case in the published literature.